Novel approaches to improve systemic bioavailability of curcumin using probiotics for rotenone-induced Parkinson's disease in rodents.

IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
American journal of translational research Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI:10.62347/TKQK8110
Arun Soni, Adarsh Patel, Sanjeev Acharya, Alkesh Patel, Umang Shah, Swayamprakash Patel, Nilay Solanki, Mehul Patel
{"title":"Novel approaches to improve systemic bioavailability of curcumin using probiotics for rotenone-induced Parkinson's disease in rodents.","authors":"Arun Soni, Adarsh Patel, Sanjeev Acharya, Alkesh Patel, Umang Shah, Swayamprakash Patel, Nilay Solanki, Mehul Patel","doi":"10.62347/TKQK8110","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>The prevalence of Parkinson's Disease (PD) is high, and treatment is not optimal to date. Curcumin possesses neuroprotective effects. Nevertheless, oral use is incommodious due to its poor bioavailability. Numerous attempts have been made to increase its systemic bioavailability. Among these, an effective way to increase the bioavailability of curcumin is by combining it with probiotics to target the glucuronidation reaction. The present study focuses on the bio-enhancement of curcumin using probiotics in animal models of PD by alleviating oxidative stress and ameliorating dopamine levels.</p><p><strong>Materials and methods: </strong>Forty-two male rats were used for the study. Twelve animals were used for a bio-availability study in which curcumin was administered orally alone and concomitantly with a probiotic (<i>Lactobacillus Rhamnus</i>, 10<sup>9</sup> <i>cfu</i>, PO) to prove probiotics' ability to enhance curcumin's serum level by inhibition of β-glucuronidase activity. Serum curcumin level was estimated using the LC-MS/MS technique on 21 days of dosing. The remaining animals were used in an experimental study. PD was induced through 2.5 mg/kg rotenone (ROT). Subsequently, the animals were allocated to five groups and treated commensurately along with ROT. Three treatment groups were administered curcumin (alone, with 10<sup>8</sup> <i>cfu</i>, with 10<sup>9</sup> <i>cfu</i>). The standard control and disease control groups were supplied with sunflower oil. Effect on behavioral patterns, neurotransmitter and enzyme levels, and oxidative stress parameters were measured. Moreover, the brain was isolated for histopathology.</p><p><strong>Results and conclusions: </strong>The bioavailability study revealed a significant (<i>P</i>-value <0.001) increase in the serum level of curcumin in concomitantly administered probiotics with curcumin-treated animals compared to curcumin-only treated animals. An experimental study showed improved behavioral parameters, brain dopamine level, acetylcholinesterase (AchE), and oxidative stress combined in the curcumin and <i>L. Rhamnosus</i> treated groups. A notable improvement in the histology of the brain was observed. These findings strongly indicate that combining <i>L. Rhamnosus</i> with curcumin may be an effective therapeutic solution.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 2","pages":"868-877"},"PeriodicalIF":1.7000,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909508/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of translational research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/TKQK8110","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim: The prevalence of Parkinson's Disease (PD) is high, and treatment is not optimal to date. Curcumin possesses neuroprotective effects. Nevertheless, oral use is incommodious due to its poor bioavailability. Numerous attempts have been made to increase its systemic bioavailability. Among these, an effective way to increase the bioavailability of curcumin is by combining it with probiotics to target the glucuronidation reaction. The present study focuses on the bio-enhancement of curcumin using probiotics in animal models of PD by alleviating oxidative stress and ameliorating dopamine levels.

Materials and methods: Forty-two male rats were used for the study. Twelve animals were used for a bio-availability study in which curcumin was administered orally alone and concomitantly with a probiotic (Lactobacillus Rhamnus, 109 cfu, PO) to prove probiotics' ability to enhance curcumin's serum level by inhibition of β-glucuronidase activity. Serum curcumin level was estimated using the LC-MS/MS technique on 21 days of dosing. The remaining animals were used in an experimental study. PD was induced through 2.5 mg/kg rotenone (ROT). Subsequently, the animals were allocated to five groups and treated commensurately along with ROT. Three treatment groups were administered curcumin (alone, with 108 cfu, with 109 cfu). The standard control and disease control groups were supplied with sunflower oil. Effect on behavioral patterns, neurotransmitter and enzyme levels, and oxidative stress parameters were measured. Moreover, the brain was isolated for histopathology.

Results and conclusions: The bioavailability study revealed a significant (P-value <0.001) increase in the serum level of curcumin in concomitantly administered probiotics with curcumin-treated animals compared to curcumin-only treated animals. An experimental study showed improved behavioral parameters, brain dopamine level, acetylcholinesterase (AchE), and oxidative stress combined in the curcumin and L. Rhamnosus treated groups. A notable improvement in the histology of the brain was observed. These findings strongly indicate that combining L. Rhamnosus with curcumin may be an effective therapeutic solution.

求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of translational research
American journal of translational research ONCOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
自引率
0.00%
发文量
552
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信